Access Bio, Inc. (KOSDAQ:950130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,570.00
0.00 (0.00%)
Sep 1, 2026, 3:30 PM KST

Access Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
237,733323,342342,245277,607473,199199,083
Short-Term Investments
8,85442.7650,10511,19813,8791,250
Trading Asset Securities
74,86979,61362,49758,17111,636-
Cash & Short-Term Investments
321,456402,997454,847346,976498,714200,333
Cash Growth
-21.45%-11.40%31.09%-30.43%148.94%297.89%
Accounts Receivable
4,6502,4417,63317,78391,22154,643
Other Receivables
1,8321,5671,6043,8791,0841,081
Receivables
6,9234,01010,14722,04692,32256,379
Inventory
16,74210,71823,46032,224114,17054,477
Prepaid Expenses
936.91441.94599.13790.421,251869.97
Other Current Assets
9,87815,10511,19016,3969,28716,132
Total Current Assets
355,935433,272500,243418,433715,744328,190
Property, Plant & Equipment
84,56056,289137,180139,506130,54780,586
Long-Term Investments
86,10561,55961,673100,9814,0000
Goodwill
24,460-----
Other Intangible Assets
4,12999.96237.86386.73445.95522.29
Long-Term Deferred Tax Assets
70,48551,63932,59925,81927,98924,139
Long-Term Deferred Charges
21.52119.1395.72816.281,0251,196
Other Long-Term Assets
5,2384,5918,1504,7055,7237,361
Total Assets
631,304607,940740,851691,136885,480442,009

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,412612.831,1513,4592,1969,737
Accrued Expenses
2,5561,62413,87914,375156,87422,221
Short-Term Debt
14,510--8,9638,88456,142
Current Portion of Long-Term Debt
24,50014,57014,690120120-
Current Portion of Leases
4,1203,6985,4044,3443,9751,932
Current Income Taxes Payable
139.46523.86502.78-8,64714,668
Current Unearned Revenue
2.34-49.8199.32--
Other Current Liabilities
3,9563,8384,72712,65815,60933,551
Total Current Liabilities
51,19624,86640,40344,017196,304138,250
Long-Term Debt
5,039--14,69014,810-
Long-Term Leases
25,06524,57745,90645,02447,63212,008
Long-Term Unearned Revenue
43.02---635.8594.76
Long-Term Deferred Tax Liabilities
21.827.792,137264.05--
Other Long-Term Liabilities
100--01,110
Total Liabilities
81,37549,45188,446103,995259,382151,962

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,9282,7262,7922,3622,3182,168
Additional Paid-In Capital
74,37371,69972,77354,21765,70461,451
Retained Earnings
499,132548,840647,142567,965590,149233,950
Treasury Stock
--39,933-40,909-35,883-32,943-4,570
Comprehensive Income & Other
-43,518-26,142-31,646-4,504-7,115-6,409
Total Common Equity
532,916557,190650,152584,155618,112286,590
Minority Interest
17,0131,2992,2532,9867,9863,457
Shareholders' Equity
549,929558,489652,405587,141626,098290,047
Total Liabilities & Equity
631,304607,940740,851691,136885,480442,009

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
73,23542,84466,00073,14175,42170,081
Net Cash (Debt)
248,221360,153388,847273,835423,293130,251
Net Cash Growth
-29.09%-7.38%42.00%-35.31%224.98%4128.83%
Net Cash Per Share
7048.8210227.6515662.318105.0811183.973491.51
Filing Date Shares Outstanding
35.1635.9835.1733.8133.9635.6
Total Common Shares Outstanding
35.1635.9835.1733.8133.9635.6
Working Capital
304,739408,405459,840374,416519,440189,940
Book Value Per Share
15156.8115486.2018483.9717276.6418199.048049.82
Tangible Book Value
504,327557,091649,914583,768617,666286,067
Tangible Book Value Per Share
14343.7015483.4218477.2117265.2018185.918035.15
Land
--4,2854,2854,2854,161
Buildings
--14,80814,80712,40212,302
Machinery
--89,71576,94948,90625,801
Construction In Progress
--4,1556,69628,74632,495